It has been suggested that some plant-derived phytochemicals from food or medicinal herbs could be therapeutically effective agents in the prevention and/or management of cancer and noncommunicable diseases associated with oxidative stress and inflammation.
In this issue, the anti-inflammatory effect of plant ingredients has been investigated by Balkrishna et al., Cui et al., and Ibrahim et al. Balkrishna et al. reported anti-inflammatory and antipsoriatic effects of a sea buckthorn oil (SBKT) derived from the fruit pulp of Hippophae rhamnoides in the carrageenan-stimulated rat paw edema model and in the 12-O tetradecanoyl phorbol 13-acetate (TPA) stimulated psoriasis-like lesion mice model, respectively. Cui et al. Patti et al. reported the antioxidant activity of Mentha longifolia L. crude extract in vitro and the antiproliferative effects on two adrenocortical tumor cell models. On the other hand, Bortolotti et al. pointed out that most existing studies on Momordica charantia (commonly called bitter melon) bioactive compounds were performed only on cell lines and in animal models and that clinical studies are needed to establish its efficacy and safety in patients. Besides, both in vitro and in vivo studies demonstrated that bitter melon may also elicit toxic or adverse effects under different conditions and few papers discuss the anti-inflammatory and anticancer properties. Moreover, in a systematic review, Medic et al. concluded that despite anthocyanins-enriched diets proved to be effective in experimental murine models of colorectal cancer, no effect in human studies was observed. A hypothesis for the different effect in murine models and human could be the relationship among nutraceuticals and microbiota (Vamanu) . From that, personalized health care for chronic noncommunicable diseases that impact quality of life should consider gut microbiota in addition to genetic and epigenetic factors, health status, polypharmacy, and moods (Sciarra et al.) .
